SEP-363856 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-20 in 3mo
ESTIMATED |
READOUT
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participan
Phase 3 · Schizophrenia |
Otsuka Pharmaceutical Development | SEP-363856 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|